Related Experiment Video

Updated: Aug 7, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

State of the art. Circulatory support

A Kantrowitz1

  • 1Sinai Hospital of Detroit, Michigan.

ASAIO Transactions
|July 1, 1988
PubMed

Insights

Chronic congestive heart failure (CCHF) significantly impacts older adults, incurring high healthcare costs. Left ventricular assist devices offer promising therapeutic potential alongside preventive strategies for managing CCHF.

Area of Science:

  • Cardiology
  • Medical Engineering

Background:

  • Chronic congestive heart failure (CCHF) is a significant health concern, particularly for individuals over 65 in the United States.
  • CCHF treatment represents a substantial financial burden, leading to the highest hospitalization charges for Medicare patients.
  • Current solutions like heart transplants are insufficient to meet the demand.

Purpose of the Study:

  • To highlight the growing challenge of chronic congestive heart failure in the aging US population.
  • To discuss the limitations of current treatments for CCHF.
  • To explore the potential of left ventricular assist devices (LVADs) as a significant component of CCHF management.

Main Methods:

  • Review of current literature on chronic congestive heart failure prevalence and costs.
  • Analysis of the role and advancements in left ventricular assist device technology.
  • Evaluation of preventive and therapeutic strategies in managing CCHF.

Main Results:

  • CCHF is a leading cause of hospitalization and expense among Medicare patients aged 65 and older.
  • While heart transplantation is a viable option, its availability is limited.
  • Significant advancements in left ventricular assist device technology are enhancing their therapeutic role.

Conclusions:

  • Left ventricular assist devices, combined with preventive and therapeutic measures, show considerable promise for addressing the CCHF epidemic.
  • Further development and integration of LVADs could significantly improve outcomes for CCHF patients.
  • A multi-faceted approach including LVADs is crucial for managing the growing burden of CCHF.

More Related Videos

The Intra-Aortic Balloon Pump06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Overview of Systemic and Pulmonary Circulation01:15

Overview of Systemic and Pulmonary Circulation

The systemic and pulmonary circuits are crucial components of the circulatory system, working together to transport blood between the heart, lungs, and the rest of the body. The process begins with pulmonary circulation, where deoxygenated blood is pumped from the right ventricle to the lungs via the pulmonary trunk and arteries. Upon reaching the lungs, the blood becomes oxygenated and returns to the heart, specifically to the left atrium, via the pulmonary veins.
The oxygenated blood is sent...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...